Patent Assignment
Reel/Frame 028866/0511
Change of Name
Recorded: 2012-08-29
Pages: 31
Assignor
SCHERING CORPORATION
Executed: 2012-05-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(968)
24-And 25-Substituted Avermectin and Milbemycin Derivatives
Patent:
5,830,875 →
Application:
07/429,919 →
Food Package Hydroxyiminoerythromycin A
Patent:
5,912,331 →
Application:
07/669,809 →
Assays for Agonists and Antagonists of Recombinant Human Calcium Channels
Patent:
5,429,921 →
Application:
07/745,206 →
Slow Release Syneresing Polymeric Drug Delivery Device
Patent:
5,411,737 →
Application:
07/776,913 →
Sample Dissolution Chamber
Patent:
5,227,303 →
Application:
07/841,932 →
Automated Sterility Testing System with Concurrent Sample Dissolving,Diluting and Mixing
Patent:
5,213,967 →
Application:
07/841,933 →
Alkylthio Alkyl Avermectins Are Active Antiparasitic Agents
Patent:
5,229,415 →
Application:
07/857,035 →
Stabilizers for Fibroblast Growth Factors
Patent:
5,348,941 →
Application:
07/861,060 →
Preparation of Oxazaborolidine Borane Complex
Patent:
5,264,574 →
Application:
07/862,647 →
Avermectin Difluoro Derivatives
Patent:
5,229,416 →
Application:
07/875,486 →
Process for Attenuated Varicella Zoster Virus Vaccine Production
Patent:
5,360,736 →
Application:
07/893,295 →
Method for Increasing Production of Disulfide Bonded Recombinant Proteins by Saccharomyces Cerevisiae
Patent:
6,291,205 →
Application:
07/901,713 →
Calcium Channel Alpha-2 Subunit Dnas and Cells Expressing Them
Patent:
5,407,820 →
Application:
07/914,231 →
Angiotensin Ii Antagonist
Patent:
5,264,447 →
Application:
07/939,893 →
Angiotensin Ii Antagonist
Patent:
5,266,583 →
Application:
07/940,253 →
Brain Derived and Recombinant Acidic Fibroblast Growth Factor
Patent:
5,401,832 →
Application:
07/951,365 →
Process of Making Chiral 2-Aryl-1,4-Butanediamine Derivatives as Use- Ful Neurokinin-a Antagonists
Patent:
5,391,819 →
Application:
07/954,215 →
Method of Clonal Growth of Streptococcus Pneumoniae
Patent:
5,314,822 →
Application:
07/961,587 →
Acidic Derivatives of Homocysteine Thiolactone
Patent:
5,274,122 →
Application:
07/963,324 →
Novel Process for Purification of Hepatitis a Virions
Patent:
5,521,082 →
Application:
07/967,920 →
O-Arly, O-Alkyl, O-Alkenyl and O-Alkynylrapamycin Derivatives
Patent:
5,258,389 →
Application:
07/973,807 →
Novel Process for the Preparation of Benzylformimidate
Patent:
5,319,122 →
Application:
07/975,306 →
Dry Mix Formulation for Bisphosphonic Acids with Lactose
Patent:
5,358,941 →
Application:
07/984,399 →
Novel Process for the Preparation of Antiulcer Agents
Patent:
5,391,752 →
Application:
08/022,804 →
15-Substituted 4-Azasteroids
Patent:
5,359,071 →
Application:
08/030,508 →
Aza Cyclohexapeptide Compounds
Patent:
5,378,804 →
Application:
08/032,847 →
Hiv Protease Inhibitors Useful for the Treatment of Aids
Patent:
5,413,999 →
Application:
08/059,038 →
Nucleic Acids Encoding Human Metabotropic Glutamate Receptors
Patent:
5,521,297 →
Application:
08/072,574 →
Novel Spirocycles
Patent:
5,382,587 →
Application:
08/085,573 →
Methods of Treating and Androgenic Alopecia with Finasteride
Patent:
5,571,817 →
Application:
08/094,815 →
Assay for Evaluating Inhibition of Polymorphonuclear Leukocyte Elastase by N-Substituted Azetidinones
Patent:
5,420,010 →
Application:
08/100,532 →
Human Neurokinin-1 Receptor
Patent:
5,484,886 →
Application:
08/117,965 →
Vascular Endothelial Cell Growth Factor C Subunit
Patent:
5,994,300 →
Application:
08/124,259 →
Process for the Preparation of 4"-Amino Avermectin Compounds
Patent:
5,362,863 →
Application:
08/128,936 →
Glycosidation Route to 4"-Epi-Methylamino-4"-Deoxyavermectin B1
Patent:
5,399,717 →
Application:
08/129,296 →
Stable Solvates of Avermectin Compounds
Patent:
5,380,838 →
Application:
08/133,494 →
Histamine H3-Receptor Antagonists and Therapeutic Uses Thereof
Patent:
5,486,526 →
Application:
08/145,903 →
Antiparasitic Agents
Patent:
5,399,582 →
Application:
08/146,638 →
Spiro Piperidines and Homologs Which Promote Release of Growth Hormone
Patent:
5,536,716 →
Application:
08/147,226 →
Dna Encoding Inducible Nitric Oxide Synthase
Patent:
5,766,909 →
Application:
08/147,812 →
New Substituted Azetidinones as Anti-Inflammatory and Antidegenerative Agents
Patent:
5,591,737 →
Application:
08/168,903 →
Process for Synthesizing Carbapenem Intermediates Using a Rhodium Catalyst and Lewis Acid
Patent:
5,493,018 →
Application:
08/186,207 →
Process for Making Hiv Protease Inhibitors
Patent:
5,463,067 →
Application:
08/187,664 →
A Protein Prenyltransferase
Patent:
5,789,558 →
Application:
08/188,277 →
Cysteine-Modified Acidic Fibroblast Growth Factor and Methods of Use
Patent:
5,409,897 →
Application:
08/189,230 →
Process for Making Avermectin/Zein Compositions
Patent:
5,436,355 →
Application:
08/191,824 →
Process for Production of an Antibiotic Compound with Zalerion Arboric Ola
Patent:
5,426,038 →
Application:
08/195,426 →
Fk-506 Cytosolic Binding Protein, FKBP12.6
Patent:
5,457,182 →
Application:
08/197,795 →
Short Synthesis of 5,6-Dihydro-(S)-4-(Ethylamino)-(S)-6-[C3H3]-4H-Thieno[2,3-B]Thiopyran- 2-Sulfonamide 7,7-Dioxide and Related Non Radioactive Compounds
Patent:
5,441,722 →
Application:
08/198,248 →
Method of Treating Androgenic Alopecia with 5-Alpha Reductase Inhibitors
Patent:
5,547,957 →
Application:
08/214,905 →
Alendronate Therapy to Prevent Loosening of, or Pain Associated with, Orthopedic Implant Devices
Patent:
5,646,134 →
Application:
08/230,670 →
Dna Encoding a Soluble Vegf Inhibitor
Patent:
5,712,380 →
Application:
08/232,538 →
Active Avermectin Analogue
Patent:
5,578,581 →
Application:
08/233,489 →
Automated Analysis Equipment and Assay Method for Detecting Cell Surface Protein and/or Cytoplasmic Receptor Function Using Same
Patent:
5,670,113 →
Application:
08/244,985 →
Oral Liquid Alendronate Formulations
Patent:
5,462,932 →
Application:
08/245,289 →
Pneumococcal Polysaccharide Conjugate Vaccine
Patent:
5,623,057 →
Application:
08/246,394 →
Bioconversion Products of 27-Hydroxy Avermectin
Patent:
5,478,929 →
Application:
08/247,173 →
Palladium Catalyzed Ring Closure of Triazolyltryptamine
Patent:
5,567,824 →
Application:
08/248,288 →
Dna Encoding Glutamate Gated Chloride Channels
Patent:
5,527,703 →
Application:
08/249,112 →
Process of Synthesizing Binaphthyl Derivatives
Patent:
5,399,771 →
Application:
08/252,306 →
Histamine H3-Receptor Antagonists and Therapeutic Uses Thereof
Patent:
5,633,382 →
Application:
08/259,926 →
Expression Cassettes Useful in Construction of Integrative and Replicative Expression Vectors for Streptomyces
Patent:
5,622,866 →
Application:
08/264,861 →
Non-Streaming Ophthalmic Tip and Delivery Device
Patent:
5,464,122 →
Application:
08/265,351 →
Reduction of Phenylalkyl Ketones to the Corresponding (S)-Hydroxy Deri Vatives Using Mucor Hiemalis Ifo 5834
Patent:
5,427,933 →
Application:
08/277,727 →
Process for Producing N-Amino-1-Hydroxy-Alkylidene-1, 1-Bisphosphonic Acids
Patent:
5,510,517 →
Application:
08/286,151 →
Automated System and Method for Simultaneously Performing a Plurality of Signal-Based Assays
Patent:
6,800,452 →
Application:
08/287,358 →
Novel Process for the Preparation of Diisopinocampheylchloroborane
Patent:
5,545,758 →
Application:
08/289,077 →
Aza Cyclohexapeptide Compounds
Patent:
5,514,650 →
Application:
08/298,479 →
Bioconversion Process for the Synthesis of Transhydroxy Sulfone by Rho Dotorula Rubra or Rhodotorula Piliminae
Patent:
5,474,919 →
Application:
08/305,110 →
4-[4'-Piperodinyl or 3'-Pirrolidinyl] Substituted Imidazoles as H3- Receptor Antagonists and Therapeutic Uses Thereof
Patent:
5,639,775 →
Application:
08/313,282 →
Defined Medium Ompc Fermentation Process
Patent:
5,494,808 →
Application:
08/332,195 →
Pour-On Formulations Containing Polymeric Material
Patent:
5,516,761 →
Application:
08/333,936 →
Process for Attenuated Varicella Zoster Virus Vaccine Production
Patent:
5,607,852 →
Application:
08/347,345 →
Antiparasitic Agents
Patent:
5,614,546 →
Application:
08/359,666 →
Controlled Release Drug Suspension Delivery Device
Patent:
5,582,838 →
Application:
08/363,451 →
Method of Prevention of Prostatic Carcinoma with 17 Beta-N-Monosubstituted-Carbamoyl-4-Aza-5-Alpha-Androst-1-En-3-Ones
Patent:
6,268,376 →
Application:
08/364,072 →
Thermodynamically Stable Crystal Form of 4"-Deoxy-4"-Epi-Methylamino Avermectin B1A/B1B Benzoic Acid Salt and Processes for Its Preparation
Patent:
6,486,195 →
Application:
08/376,318 →
Process for the Preparation of 1-(Thiomethyl)-Cyclopropaneacetic Acid
Patent:
5,523,477 →
Application:
08/376,715 →
Process for Preparing Certain Aza Cyclohexapeptides
Patent:
5,552,521 →
Application:
08/386,618 →
Anthelmintic Use of Nodulisporic Acid and Analogs Thereof
Patent:
5,595,991 →
Application:
08/406,447 →
Hiv Protease Inhibitors Useful for the Treatment of Aids
Patent:
5,527,799 →
Application:
08/407,740 →
Dna Encoding Human Papillomavirus Type 18
Patent:
5,840,306 →
Application:
08/408,669 →
Recombinant Human Papillomavirus Type 18 Vaccine
Patent:
5,820,870 →
Application:
08/409,122 →
Dual Jet Crystallizer Apparatus
Patent:
5,578,279 →
Application:
08/411,614 →
A Process for the Production of Finasteride
Patent:
5,652,365 →
Application:
08/411,685 →
A Stable, Ready-to-Use Pharmaceutical Paste Composition Containing Proton Pump Inhibitors
Patent:
5,708,017 →
Application:
08/416,275 →
Method for Alleviating Varicella Related Post-Herpetic Neuralgia
Patent:
5,997,880 →
Application:
08/419,223 →
Substituted Pyridines Useful as Modulators of Acetylcholine Receptors
Patent:
5,585,388 →
Application:
08/419,597 →
Ophthalmic Package and Delivery Device
Patent:
5,624,057 →
Application:
08/432,500 →
Enzymatic Hydrolysis of 3,3-Diethyl-4-[(4-Carboxy)Phenoxy]-2-Azetidinone Esters
Patent:
5,523,233 →
Application:
08/433,586 →
Automated Assays and Methods for Detecting and Modulating Cell Surface Protein Function
Patent:
6,057,114 →
Application:
08/434,511 →
Dna Encoding Glutamate Gated Chloride Channels
Patent:
5,693,492 →
Application:
08/435,933 →
Process for the Preparation of Leukotriene Antagonists
Patent:
5,614,632 →
Application:
08/439,733 →
Genes Which Influence Pichia Proteolytic Activity, and Uses Therefor
Patent:
5,691,166 →
Application:
08/441,750 →
Genes Which Influence Pichia Proteolytic Activity, and Uses Therefor
Patent:
5,831,053 →
Application:
08/441,751 →
Substituted Sulfonamides as Selective B3 Agonists for the Treatment of Diabetes and Obesity
Patent:
5,561,142 →
Application:
08/445,630 →
Treatment of Migraine with Morpholine Tachykinin Receptor Antagonists
Patent:
5,716,942 →
Application:
08/450,198 →
Human Calcium Channel Compositions and Methods
Patent:
6,653,097 →
Application:
08/450,273 →
Asymmetric Synthesis of (-)6-Chloro-4-Cyclopropyl-Ethynyl-4-Trifluoromethyl-1,4-Dihydro-2H-3,1 -Benzoxanzin-2-One
Patent:
5,633,405 →
Application:
08/450,330 →
Treatment of Emesis with Morphlime Tachykinin Receotor Antagonists
Patent:
5,512,570 →
Application:
08/450,507 →
Human Calcium Channel Compositions and Methods
Patent:
6,096,514 →
Application:
08/450,562 →
Methods of Treating Androgenic Alopecia with Finasteride [17B-N-Mono- Substituted-Carbamoyl-4-Aza-5-Alpha-Androst-1-En-Ones]
Patent:
5,567,708 →
Application:
08/455,464 →
Human Calcium Channel Compositions and Methods
Patent:
5,792,846 →
Application:
08/455,543 →
Benzoxazinones as Inhibitors of Hiv Reverse Transcriptase
Patent:
5,663,169 →
Application:
08/458,528 →
Benzoxazinones as Inhibitors of Hiv Reverse Transcriptase
Patent:
5,665,720 →
Application:
08/458,529 →
Benzoxazinones as Inhibitors of Hiv Reverse Transcriptase
Patent:
5,519,021 →
Application:
08/460,026 →
Dna Encoding the Human Neurokinin-1 Receptor
Patent:
5,525,712 →
Application:
08/463,488 →
16-Substituted-4-Aza-Androstane 5-Alpha-Reductase Isozyme 1 Inhibitors
Patent:
5,719,158 →
Application:
08/463,544 →
Capped Synthetic Rna, Analogs, and Aptamers
Patent:
6,111,095 →
Application:
08/480,068 →
Modulators of Acetylcholine Receptors
Patent:
5,703,100 →
Application:
08/485,398 →
Process for Making an Epoxide
Patent:
5,728,840 →
Application:
08/512,602 →
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Patent:
5,719,147 →
Application:
08/525,259 →
Morpholine Compounds Are Prodrugs Useful as Tachykinn Receptor Antagonists
Patent:
5,691,336 →
Application:
08/525,870 →
Combination of an Ace Inhibitor and a Diuretic
Patent:
5,686,451 →
Application:
08/526,142 →
Pour-On Formulations Consisting of Gylcols,Glycerides and Avermectin Compounds
Patent:
5,602,107 →
Application:
08/561,208 →
Culture Medium for Saccharomyces Cerevisiae
Patent:
5,795,771 →
Application:
08/578,719 →
Novel Process for the Preparation of Diisopinocampheylchloroborane
Patent:
5,693,816 →
Application:
08/586,037 →
Method of Treating Androgenic Alopecia with 5-Alpha Reductase Inhibitors
Patent:
5,824,686 →
Application:
08/596,339 →
16-Substituted-4-Aza-3-Oxo-Androstane as 5--Alpha-Reductase Isozyme 1 Inhibitors
Patent:
5,739,137 →
Application:
08/601,042 →
Aza Cyclohexapeptide Compounds
Patent:
5,668,105 →
Application:
08/614,452 →
Asymmetric Synthesis of (-)6-Chloro-4-Cyclopropyl-Ethynyl-4- Trifluoromethyl-1,4-Dihydro-2H-3,1-Benzoxazin-2-One
Patent:
5,698,741 →
Application:
08/680,940 →
Triazolylmethyl-Indole Ethylamine Bisulfate Salt
Patent:
5,834,502 →
Application:
08/682,815 →
Production of Recombinant Human Papillomavirus Type Ii Protein Utilizing Papillomavirus 6/11 Hybrid Dna
Patent:
5,821,087 →
Application:
08/710,082 →
Method for Analyzing the Immunosuppressant Activity of Ion Channel Blockers Using the Mini-Pig
Patent:
5,837,220 →
Application:
08/711,576 →
Histone Deacetylase as Target for Antiprotozal Agents
Patent:
6,110,697 →
Application:
08/716,978 →
Aza Cyclohexapeptide Compounds
Patent:
5,792,746 →
Application:
08/741,645 →
Substituted Pyridyl Pyrroles, Compositions Containing Such Compounds and Methods of Use
Patent:
5,776,954 →
Application:
08/742,428 →
Homologous Recombination Antibody Expressions System for Murine Cells
Gender-Specific Fading Down Turkey Breed
Patent:
5,959,172 →
Application:
08/757,497 →
Hiv Protease Inhibitors Useful for the Treatment of Aids
Patent:
5,717,097 →
Application:
08/759,203 →
New Substituted Azetidinones as Anti-Inflammatory and Antidegenerative Agents
Patent:
5,952,321 →
Application:
08/764,775 →
Piperidines and Hexahydro-1H-Azepines Spiro Substituted at the 4-Position Promote Release of Growth Hormone
Patent:
5,783,582 →
Application:
08/776,041 →
Inhibitro of Vascular Endothelial Cell Growth Factor
Patent:
5,861,484 →
Application:
08/786,164 →
Capped Synthetic Rna, Analogs, and Aptamers
Patent:
5,861,501 →
Application:
08/807,104 →
Benzoxazinones as Inhibitors of Hiv Reverse Transcriptase
Patent:
5,811,423 →
Application:
08/815,780 →
Finasteride Processes
Patent:
5,886,184 →
Application:
08/824,426 →
Carbapenem Antibacterial Compounds, Compositions Containing Such Compounds and Methods of Treatment
Patent:
5,756,725 →
Application:
08/825,786 →
Antifungal Compositions
Patent:
5,952,300 →
Application:
08/827,510 →
Piperidines, Pyrrolidines and Hexahydro-1H-Azepines Promote Release Ofgrowth Hormone
Patent:
5,804,578 →
Application:
08/828,606 →
Leptin Assay
Patent:
6,007,998 →
Application:
08/837,635 →
New Substituted Azetidinones as Anti-Inflammatory and Antidegenerative Agents
Patent:
5,747,485 →
Application:
08/848,076 →
Effervescent Alendronate Formulation
Patent:
5,853,759 →
Application:
08/848,460 →
Novel Chiral Bisphosphines
Patent:
5,874,629 →
Application:
08/866,665 →
Process for Preparing Certain Aza Cyclohexapeptides
Patent:
5,936,062 →
Application:
08/874,118 →
Process for Synthesizing Carbapenem Antibiotics
Patent:
5,872,250 →
Application:
08/887,849 →
Morpholine Compounds Are Prodrugs Useful as Tachykinin Receptor Antagonists
Patent:
5,780,467 →
Application:
08/907,738 →
Palladium Catalyzed Indolization
Patent:
5,808,064 →
Application:
08/908,683 →
Synthetic HPV6/11 Hybrid L1 Dna Encoding Human Papillomavirus Type 11 L1 Protein
Patent:
6,159,729 →
Application:
08/913,462 →
Dna Encoding Human Papilloma Virus Type 18
Patent:
6,908,615 →
Application:
08/913,644 →
Antiparasitic Agents
Patent:
5,834,260 →
Application:
08/914,998 →
Sordarin Derivatives
Patent:
6,040,463 →
Application:
08/936,462 →
Rotavirus Vaccine Formulations
Patent:
5,932,223 →
Application:
08/938,260 →
Dry Mix Formulation for Bisphosphonic Acids
Patent:
5,882,656 →
Application:
08/946,849 →
Human Calcium Channel Beta-4 Subunits
Patent:
6,090,623 →
Application:
08/949,386 →
Method for Large Scale Plasmid Purification
Patent:
6,197,553 →
Application:
08/952,428 →
Process for the Crystallization of Losartan
Patent:
5,859,258 →
Application:
08/959,209 →
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Patent:
5,872,116 →
Application:
08/959,393 →
Combination Therepy for the Treatment of Diabetes and Obesity
Patent:
5,908,830 →
Application:
08/961,749 →
Recombinant Papillomavirus Vaccines
Patent:
5,888,516 →
Application:
08/969,523 →
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Patent:
5,922,706 →
Application:
08/969,685 →
Homologous Recombination Antibody Expression System for Murine Cells
Capped Synthetic Rna, Analogs and Aptamers
Patent:
6,369,208 →
Application:
08/973,137 →
Alpha La Adrenercic Receptor Antagonists
Patent:
5,977,115 →
Application:
08/973,624 →
Method for Reducing Mortality with an Angiotensin Ii Antagonist
Patent:
6,201,002 →
Application:
09/003,159 →
Process for the Crystallization of a Reverse Transcriptase Inhibitor Using an Anti-Solvent
Patent:
5,965,729 →
Application:
09/008,824 →
Preservatives for Vaccines
Patent:
6,790,445 →
Application:
09/019,764 →
Dry Granulation Formulation for an Hiv Protease Inhibitor
Patent:
6,645,961 →
Application:
09/045,885 →
Nodulisporic Acid Derivatives
Patent:
5,962,499 →
Application:
09/046,052 →
Novel Receptor
Patent:
6,545,137 →
Application:
09/060,299 →
Carbapenem Antibotic, Composition and Method of Preparation
Patent:
5,952,323 →
Application:
09/064,426 →
Wet Granulation Formulation of a Growth Hormone Secretagogue
Patent:
6,123,964 →
Application:
09/066,469 →
Efficient Enantioselective Addition Reaction Using an Organozinc Reagent
Patent:
6,015,926 →
Application:
09/075,476 →
Growth Hormone Secretagogue Receptor Family
Patent:
6,531,314 →
Application:
09/077,674 →
Alendronate Therapy to Prevent Loosening of, or Pain Associated with, Orthopedic Implant Devices
Patent:
5,972,913 →
Application:
09/082,237 →
Polysaccharide Precipitation Process
Patent:
6,410,025 →
Application:
09/088,381 →
Stabilized Carbapenem Intermediates and Improved Process for Carbapenem Synthesis
Patent:
6,180,783 →
Application:
09/093,813 →
Crystalline Forms of Antibiotic Side Chain Intermediates
Patent:
5,965,747 →
Application:
09/102,449 →
Composition and Method for Preventing Pine Wilting Disease
Patent:
5,945,445 →
Application:
09/109,190 →
4-Cyano-4-Deformylsordarin Derivatives
Patent:
5,972,996 →
Application:
09/123,230 →
4-Cyano-4-Deformylsordaricin Derivatives
Patent:
5,965,612 →
Application:
09/123,236 →
Method for Inhibiting Bone Resorption
Patent:
5,994,329 →
Application:
09/134,214 →
Method for Inhibiting Bone Resortion
Patent:
6,015,801 →
Application:
09/134,215 →
Large Scale Affinity Chromatography of Macromolecules
Patent:
6,372,425 →
Application:
09/140,201 →
Dry Mix Formulation for Bisphosphonic Acids
Patent:
6,090,410 →
Application:
09/141,782 →
Process for Enhancing the Optical Purity
Patent:
5,952,528 →
Application:
09/145,667 →
9A-Azalides as Veterinary Antimicrobal Agetns
Patent:
6,054,434 →
Application:
09/149,940 →
Long Acting Injectable Formulations Containing Hydrogenated Castor Oil
Patent:
6,174,540 →
Application:
09/152,775 →
Process for Making Diaryl Pyridines Useful as Cox-2-Inhibitors
Patent:
6,040,450 →
Application:
09/153,405 →
Antiparasitic Agents
Patent:
5,945,317 →
Application:
09/157,862 →
Assays for Nuclear Receptor Agonists and Antagonists Using Fluorescence Resonance Energy Transfer
Patent:
6,689,574 →
Application:
09/166,265 →
Omeprazole Process and Compositions Thereof
Patent:
6,166,213 →
Application:
09/169,231 →
Serum-Free, Low-Protein Media for Rotavirus Vaccine Production
Patent:
6,656,719 →
Application:
09/176,492 →
Prevention of Precipitated Acute Urinary Retention
Patent:
5,942,519 →
Application:
09/178,138 →
Method of Improved Mixing in Roller Bottles
Patent:
6,096,544 →
Application:
09/178,974 →
Human Glycine Transporter Type 2
Patent:
6,416,975 →
Application:
09/191,468 →
Integrin Receptor Antagonists
Patent:
6,017,926 →
Application:
09/212,079 →
Polymorphic Form of a Tachykinin Receptor Antagonist
Patent:
6,096,742 →
Application:
09/212,511 →
Dna Pharmaceutical Formulations Comprising Citrate or Triethanolamine and Combinations Thereof
Patent:
6,387,695 →
Application:
09/218,590 →
Efficient Synthesis of a 1,4-Dihydro-2H-3,1-Benzoxazin-2-One
Patent:
6,114,569 →
Application:
09/224,923 →
Novel Chiral Bisphosphines
Patent:
6,043,387 →
Application:
09/243,859 →
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Patent:
6,048,859 →
Application:
09/251,190 →
Nodulisporic Acid Derivatives
Patent:
6,221,894 →
Application:
09/269,010 →
Sulfurpentafluorophenylpyrazoles for Controlling Ectoparasitic Infestations
Patent:
6,136,838 →
Application:
09/271,092 →
Liquid Polymeric Compositions for Controlled Release of Bioactive Substances
Process for the Preparation of Leukotriene Antagonists
Patent:
6,320,052 →
Application:
09/274,062 →
Methods of Treating or Preventing Cardiac Arrhythmia
Patent:
6,214,809 →
Application:
09/284,704 →
Methods of Treating or Preventing Cardiac Arrhythmia
Patent:
6,214,810 →
Application:
09/284,705 →
Histone Deacetylase as Target for Antiprotozoal Agents
Patent:
6,428,983 →
Application:
09/296,834 →
Process for Synthesizing Cox-2 Inhibitors
Patent:
6,040,319 →
Application:
09/298,127 →
Pesticidal Formulation
Patent:
6,387,388 →
Application:
09/318,111 →
Rotavirus Vaccine Formulations
Patent:
6,403,098 →
Application:
09/366,616 →
Method for Preventing Zoster or Alleviating Varicella Related Post-Herpetic Neuralgia
Patent:
6,214,354 →
Application:
09/372,535 →
Enhancement of Return to Independent Living Status with a Growth Hormone Secretagogue
Patent:
6,194,402 →
Application:
09/386,177 →
Omeprazole Process and Compositions Thereof
Patent:
6,147,103 →
Application:
09/387,945 →
Method for Inhibiting Bone Resorption
Patent:
6,432,932 →
Application:
09/388,659 →
Novel Ldl-Receptor
Patent:
6,555,654 →
Application:
09/402,923 →
Radiolabeled Neurokinin-1 Receptor Antagonists
Patent:
6,241,964 →
Application:
09/407,822 →
Heterocyclic Potassium Channel Inhibitors
Patent:
6,303,637 →
Application:
09/422,500 →
Thrombin Inhibitors
Patent:
6,610,692 →
Application:
09/429,741 →
Dry Mix Formulation for Bisphosphonic Acids
Patent:
6,194,004 →
Application:
09/432,859 →
Histone Deacetylase as Target for Antiprotozoal Agents
Patent:
6,068,987 →
Application:
09/443,003 →
Polymorphic Form of a Tachykinin Receptor Antagonist
Patent:
6,229,010 →
Application:
09/458,168 →
Omeprazole Process and Compositions Thereof
Patent:
6,191,148 →
Application:
09/461,605 →
Process for Synthesizing Carbapenem Antibiotics
Patent:
6,504,027 →
Application:
09/487,044 →
Human papillomavirus vaccine formulations
Patent:
6,251,678 →
Application:
09/496,812 →
9A-Azalides as Veterinary Antimicrobial Agents
Patent:
6,339,063 →
Application:
09/508,489 →
Pharmaceutical composition containing proton pump inhibitors
Patent:
6,316,481 →
Application:
09/510,312 →
DNA encoding human papillomavirus type 6a
Patent:
6,290,965 →
Application:
09/521,526 →
Method for treating pediculosis capitis infestation
Patent:
6,262,031 →
Application:
09/523,335 →
Human Papilloma virus vaccine with disassembled and reassembled virus-like particles
Patent:
6,245,568 →
Application:
09/524,624 →
Morpholine and thiomorpholine tachykinin receptor antagonists
Patent:
6,235,735 →
Application:
09/526,843 →
Substituted piperidines as melanocortin-4 receptor agonists
Patent:
6,350,760 →
Application:
09/585,111 →
Pyrazinone Thrombin Inhibitors
Patent:
6,455,532 →
Application:
09/585,112 →
N-cyclopentyl modulators of chemokine receptor activity
Patent:
6,358,979 →
Application:
09/590,750 →
Amido Spiropiperidines Promote the Release of Growth Hormone
Patent:
6,420,376 →
Application:
09/614,193 →
Stablized human papillomavirus formulations
Patent:
6,358,744 →
Application:
09/624,482 →
Rotavirus Vaccine Formulations
Patent:
6,616,931 →
Application:
09/631,807 →
Novel Process for Making Human Papillomavirus Virus-Like Particles with Improved Properties
Patent:
6,436,402 →
Application:
09/684,233 →
Process for Formulation of Carbapenem Antibiotic Compositions
Patent:
6,548,492 →
Application:
09/698,808 →
Thrombin Receptor Antagonists
Patent:
6,544,982 →
Application:
09/698,811 →
Anticoccidial compounds
Patent:
6,384,052 →
Application:
09/709,959 →
Diaryl piperidyl pyrrole derivatives as antiprotozoal agents
Patent:
6,291,480 →
Application:
09/710,147 →
Process for making diaryl pyridines useful as cox-2 inhibitors
Patent:
6,369,275 →
Application:
09/715,736 →
Polymorphic, Amorphous and Hydrated Forms of 5-Chloro-3-(4-Methanesulfonylphenyl)-6'- Methyl-[2,3']Bipyridinyl
Patent:
6,441,002 →
Application:
09/724,522 →
Compositions and Methods for Exon Profiling
Patent:
7,807,447 →
Application:
09/724,538 →
Method for Inhibiting Bone Resorption
Process for Purifying Human Papillomavirus Virus-Like Particles
Patent:
6,602,697 →
Application:
09/762,662 →
Protein Delivery System Using Human Papillomavirus Virus-Like Particles
Patent:
6,991,795 →
Application:
09/762,794 →
Alpha V Integrin Receptor Antagonists
Thrombin Receptor Antagonists
Estrogen Receptor Modulators
Method for Inhibiting Bone Resorption
Morpholine and Thiomorpholine Tachykinin Receptor Antagonists
Process for Preparing 3-Hydroxymethyl-4-(Aryl or Heterocyclic)-Cyclopentanones
Process for Formulation of Antibiotic Compounds
Polymorphic Form of a Tachykinin Receptor Antagonist
5-Chloro-3-(4-Methanesulfonylphenyl)-6'-Methyl-[2,3']Bipyridinyl in Pure Crystalline Form and Process for Synthesis
Pyrazinone Thrombin Inhibitors
Method of Prevention of Prostatic Carcinoma with 17BETA-N-Monosubstituted-Carbamoyl-4-Aza-5ALPHA-Androst-1-En-3-Ones
Treatment for Cardiovascular Disease
Compressed Tablet Formulation
Nonacyclic nodulisporic acid derivatives
C1 to C4 Side Chain Modified Nodulisporic Acid Analogs
Patent:
6,586,452 →
Application:
09/901,266 →
Radioligand and Binding Assay
Thrombin Inhibitors
Purification Process
5-Chloro-3-(4-Methanesulfonylphenyl)-6'-Methyl-[2,3]Bipyridinyl in Pure Crystalline Form and Process for Synthesis
Aza- and Polyaza-Naphthalenyl Carboxamides Useful as Hiv Integrase Inhibitors
Dry Mix Formulation for Bisphosphonic Acids
Crystal Forms of (-)-6-Chloro-4-Cyclopropylethynyl-4-Trifluoromethyl-1,4-Dihydro-2H-3,1-Benzoxazin-2-One
Method of Treatment with a Combination of a PDE4 Inhibitor and a Leukotriene Antagonist
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
N-Cyclopentyl Modulators of Chemokine Receptor Activity
N-Substituted Nonaryl-Heterocyclic Nmda/NR2B Antagonists
Stopper Debris Separator
Inhibitor of Vascular Endothelial Cell Growth Factor
Process for the Scaleable Purification of Plasmid Dna
Thrombin Inhibitors
Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Human glycine transporter type 2
Application:
10/191,813 →
Publication:
US US20030165907A1
Dna Molecules Encoding Ligand-Gated Ion Channels from Drosophila Melanogaster
Thiazolyl(Pyridyl)Ethyne Compounds
Polymorphic Form of a Tachykinin Receptor Antagonist
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Pharmaceutical Composition of a Tachykinin Receptor Antagonist
Antifungal Combination Therapy
Patent:
38,984 →
Application:
10/325,137 →
Method of Screening for Modulator of LRP5 Activity
5-Chloro-3-(4-Methanesulfonylphenyl)-6'-Methyl-[2,3']Bipyridinyl in Pure Crystalline Form and Process for Synthesis
Anti-hypercholesterolemic drug combination
Process for Making Spirolactone Compounds
N-Biphenyl(Substituted Methyl) Aminocycloalkane-Carboxamide Derivatives
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
Isoquinolinone Potassium Channels Inhibitors
Substituted Amides
Aza-And Polyaza-Naphthalenyl-Carboxamides Useful as Hiv Integrase Inhibitors
Pyrrolidine Modulators of CCR5 Chemokine Receptor Activity
Mammalian Metabolites of a Tachykinin Receptor Antagonist
Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
Conjugates and Compositions for Cellular Delivery
Thrombin Inhibitors
11-Beta-Hydroxysteroid Dehydrogenase 1 Inhibitors Useful for the Treatment of Diabetes, Obesity and Dyslipidemia
Process for Carbapenem Synthesis
Thrombin Inhibitors
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
N-Substituted Nonaryl-Heterocyclic Nmda/NR2B Antagonists
Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Inhibitors of Akt Activity
Inhibitors of Akt Activity
Echinocandin Process
Dipeptidyl Peptidase Inhibitors for the Treatment of Diabetes
Phenylalanine Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Beta-Amino Tetrahydroimidazo (1, 2-a) Pyrazines and Tetrahydrotrioazolo (4,3-a) Pyrazines as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Dipeptidyl Peptidase Inhibitors for the Treatment of Diabetes
Radiolabeled Neuropeptide Y Y5 Receptor Antagonists
Process for Making Carbapenem Compounds
Crystalline Forms of Carbapenem Antibiotics and Methods of Preparation
Benzimisazo[4,5-F]Isoquinolinone Derivatives
Interactive Product Selection System
Histamine Receptor H4 Polynucleotides
Isolated Dna Molecules Encoding Humanized Calcitonin Gene-Related Peptide Receptor, Related Non-Human Transgenic Animals and Assay Methods
Heteroaryl Substituted Tetrazole Modulators of Metabotrophic Glutamate Receptor-5
Hepatitis C Virus Vaccine
Heteroaryl Substituted Pyrazole Modulators of Metabotropic Glutamate Receptor-5
Staphylococcus Aureus Exopolysaccharide and Process
Hydroxynaphthyridinone Carboxamides Useful as Hiv Integrase Inhibitors
Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
N-Biphenylmethyl Aminocycloalkanecarboxamide Derivatives
Methods of Inhibiting Orthopoxvirus Replication with Nucleoside Compounds
Pharmaceutical Treatment Blister Card
Di-Aryl Substituted Tetrazole Modulators of Metabotropic Glutamate Receptor-5
Mitotic Kinesin Inhibitors
Fluorinated 4-Azasteroid Derivatives as Androgen Receptor Modulators
Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Inhibitors of Akt Activity
Inhibitors of Akt Activity
Aminoalkylphenols, Methods of Using and Making the Same
Process for 5-[[2(R)-[1(R)-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3(S)-(4-Fluorophenyl)-4-Morpholinyl]Methyl]-1,2-Dihydro-3H-1,2,4-Triazol-3-One
Estrogen Receptor Modulators
Methods of Adenovirus Purification
Computer Systems and Methods for Subdividing a Complex Disease into Component Diseases
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
Piperidino Pyrimidine Dipeptidyl Peptidase Inhibitors for the Treatment of Diabetes
Thionucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Tyrosine Kinase Inhibitors
Indoles Having Anti-Diabetic Activity
Piperazine Urea Derivatives as Melanocortin-4 Receptor Agonists
Using Amines or Amino Acids as Mobile Phase Modifiers in Chromatography
Estrogen Receptor Modulators
Radiolabeled Neurokinin-1 Receptor Antagonists
Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors for Diabetes
Inhibitors of Akt Activity
Process for Making Spirolactone Compounds
Mitotic Kinesin Inhibitors
Phenylcarboxamide Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Phenylalanine Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Substituted Amides
Macrocyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
3-Amino-4-Phenylbutanoic Acid Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
3-Amino-4-Phenylbutanoic Acid Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Substituted Pyrazoles, Compositions Containing Such Compounds and Methods of Use
Method to Confer Cell Culture Replication Activity to Different Hepatitis C Virus Isolates
Process to Branched Ribonucleosides
Carboxamide Spirohydantoin Cgrp Receptor Antagonists
Monocyclic Anilide Spirohydantoin Cgrp Receptor Antagonists
Aryl Spirohydantoin Cgrp Receptor Antagonists
Benodiazepine Spirohydantoin Cgrp Receptor Antagonists
Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Agonists
Bicyclic Anilide Spirohydantoin Cgrp Receptor Antagonists
Process for the Preparation of Chiral Beta Amino Acid Derivatives by Asymmetric Hydrogenation
Optimized Expression of HPV31 L1 in Yeast
Cgrp Receptor Antagonists
Androgen Receptor Modulators and Methods of Use Thereof
Inhibitors of Akt Activity
Inhibitors of Akt Activity
Inhibitors of Akt Activity
Inhibitors of Akt Activity
Forward Mutation Assay Based on 5-Fluorouracil Resistance
Benzamidazoles, Compositions Containing Such Compounds and Methods of Use
3-Amino-4-Phenylbutanoic Acid Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Triazole Derivatives as Inhibitors of 11-Beta Hydroxysteroid Dehydrogenase-1
Fused Indoles as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
3-Fluoro-Piperidines as Nmda/NR2B Antagonists
Prodrugs of Mitotic Kinesin Inhibitors
Antibiotic Compounds
Cyclohexylglycine Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Benzodiazepine Cgrp Receptor Antagonists
Benzodiazepine Cgrp Receptor Antagonists
N-Alkyl Phenylcarboxamide Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Hexahydrodiazepinones as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Macrocyclic Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Ophthalmic Compositions for Treating Ocular Hypertension
Quinoline Potassium Channel Inhibitors
Isoquinolinone Potassium Channel Inhibitors
Isoquinolinone Potassium Channel Inhibitors
Isoquinolinone Potassium Channel Inhibitors
Quinoline Potassium Channel Inhibitors
Isoquinoline Potassium Channel Inhibitors
Quinazoline Potassium Channel Inhibitors
Isoquinoline Potassium Channel Inhibitors
Isoquinolinone Potassium Channel Inhibitors
Fused Phenylalanine Derivatives as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Benzylether and Benzylamino Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Optimized Expression of Hpv 45 L1 in Yeast
Antiprotozoal Imidazopyridine Compounds
Ccr-2 Antagonist Salt
Process for the Preparation of Ccr-2 Antagonists
Hcv Replicons Containing NS5B from Genetype 2B
Method of identifying responders to treatment with insulin sensitizers
Application:
10/578,811 →
Publication:
US US20070098636A1
Benzylether and Benzylamino Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Optimized Expression of Hpv 58 L1 in Yeast
Cynomolgus Monkey Dickkopf-4, Nucleotides Encoding Same, and Uses Thereof
Rhesus Monkey Dickkopf-1, Nucleotides Encoding Same, and Uses Thereof
Cyclic Guanidines, Compositions Containing Such Compounds and Methods of Use
Phenylamide and Pyridylamide Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Alpha-Hydroxy Amides as Bradykinin Antagonists or Inverse Agonists
NPCIL1 (NPC3) and Methods of Identifying Ligands Thereof
Polynucleotides Encoding Coccidian Parasite Casein Kinase I, a Chemotherapeutic Target for Antiprotozoal Agents
Hydroisoindoline Tachykinin Receptor Antagonists
Novel Crystalline Forms of an Inhibitor of 11-Beta-Hydroxysteroid Dehydrogenase Type 1
Cgrp Receptor Antagonists
Hiv Integrase Inhibitors
Process for Large Scale Production of Plasmid Dna by E.Coli Fermentation
Stereoselective Synthesis of a 4,4-Disubstituted Cyclohexanepropanoic Acid
Polypeptides for inducing a protective immune response against staphyloococcus aureus
Application:
10/589,381 →
Publication:
US US20070134263A1
Vla-4 Antagonists
Hiv Integrase Inhibitors
Heteroaryl Piperidine Glycine Transporter Inhibitors
Optimized Expression of Hpv 52 L1 in Yeast
Process for the Synthesis of Trifluorophenylacetic Acids
Ophthalmic Compositions for Treating Ocular Hypertension
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
11-Beta-Hydroxysteroid Dehydrogenase 1 Inhibitors Useful for the Treatment of Diabetes, Obesity and Dyslipidemia
Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Adenovirus Formulations
Biaryl Substituted Triazoles as Sodium Channel Blockers
Mass Spectrometry Data Analysis Techniques
Cgrp Receptor Antagonists
Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
Phosphoric Acid Salt of a Dipeptidyl Peptidase-Iv Inhibitor
Crystal Forms of (-)-6-Chloro-4-Cyclopropylethynyl-4-Trifluoromethyl-1,4-Dihydro-2H-3,1-Benzoxazin-2-One
Fluorinated 2,4-diaryl-2,5-dihydropyrrole Inhibitors of the Mitotic kinesin KSP
Process for the Scaleable Purification of Plasmid Dna
Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
Fluorescence Assay for Measuring the Rate of Cholesterol Ester Transfer
Substituted Triazoles as Sodium Channel Blockers
Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Hydroisoindoline Tachykinin Receptor Antagonists
Adenovirus Formulations
Asymmetric Hydrogenation Process
Process for Preparing Fluoroleucine Alkyl Esters
Benzoxazinyl-Amidocyclopentyl-Heterocyclic Modulators of Chemokine Receptors
Pyrazole Derivatives, Compositions Containing Such Compounds and Methods of Use
N-(2-Benzyl)-2-Phenylbutanamides as Androgen Receptor Modulators
Cgrp Receptor Antagonists
Anti-Hypercholesterolemic Compounds
Cetp Inhibitors
Potassium Channel Inhibitors
Inhibitors of Akt Activity
Anti-Addl Antibodies and Uses Thereof
Potassium Salt of an Hiv Integrase Inhibitor
Inhibitor of vascular endothelial cell growth factor
Application:
11/375,523 →
Publication:
US US20070010442A1
Effervescent bisphosphonate formulation
Application:
11/390,114 →
Publication:
US US20070087052A1
Methods for Characterizing Agonists and Partial Agonists of Target Molecules
Compressed Tablet Formulation
System and Method for Automated Selection of T-Cell Epitopes
Dna Vaccine Formulations
Tyrosine Kinase Inhibitors
Hcv NS3 Protease Inhibitors
Novel Spirochromanone Derivatives
Spiropiperidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Hiv Reverse Transcriptase Inhibitors
Phenylcarboxamide Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Influenza recombinant subunit vaccine
Application:
11/506,539 →
Publication:
US US20080008725A1
Process for Making Fluoroleucine Ethyl Esters
Anti-Hypercholesterolemic Compounds
Inhibitors of Akt Activity
Process for the Preparation of Enantiomerically Enriched Beta Amino Acid Derivatives
Inhibitors of Akt Activity
2,4,6-Substituted Pyridyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Anti-Addl Antibodies and Uses Thereof
1,3,5-Substituted Phenyl Derivative Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Cetp Inhibitors
Cyclohexylalanine Derivatives as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Hiv Integrase Inhibitors
Acyl Indoles, Compositions Containing Such Compounds and Methods of Use
Anti-Addl Monoclonal Antibody and Use Thereof
Non-Immunostimulatory Antibody and Compositions Containing the Same
Antibiotic Compound
1,2,4-Oxadiazole Derivatives as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Spirocyclic Compounds
Human Antibodies Interacting with Hiv GP41
Covalently Stabilized Chimeric Coiled-Coil Hiv GP41 N-Peptides with Improved Antiviral Activity.
C-Purine Nucleoside Analogs as Inhibitors of Rna-Dependent Rna Viral Polymerase
N-(2-Benzyl)-2-Phenylbutanamides as Androgen Receptor Modulators
Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
Application:
11/628,934 →
Publication:
US US20070265222A1
Pyrrolidin-3-Yl Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Ophthalmic Compositions for Treating Ocular Hypertension
Mitotic Kinesin Inhibitors
Mitotic Kinesin Inhibitors
Pyrazole Amide Derivatives, Compositions Containing Such Compounds and Methods of Use
Substituted Pyrazoles, Compositions Containing Such Compounds and Methods of Use
Polymorphs of an Androgen Receptor Modulator
Ophthalmic Compositions for Treating Ocular Hypertension
Potassium Channel Inhibitors
Sulfonyl Compounds as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Inhibitors of Akt Activity
Vla-4 Antagonists
Fused Triazole Derivatives as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Pharmaceutical composition containing a cyclooxygenase-2 inhibitor and a proton pump inhibitor
Application:
11/660,195 →
Publication:
US US20080096927A1
Histone Deacetylase Inhibitors
Amorphous Form of a Phosphoric Acid Salt of a Dipeptidyl Peptidase-Iv Inhibitor
Carboxamide Spirolactam Cgrp Receptor Antagonists
Monocyclic Anilide Spirolactam Cgrp Receptor Antagonists
Aminopiperidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Tricyclic Anilide Spirolactam Cgrp Receptor Antagonists
Aryl Spirolactam Cgrp Receptor Antagonists
Tricyclic Anilide Spirohydantion Cgrp Receptor Antagonists
Bicyclic Anilide Spirolactam Cgrp Receptor Antagonists
Formulations of Suberoylanilide Hydroxamic Acid and Methods for Producing Same
Spiropiperidine Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer' S Disease
Assay for Cytochrome P450 Isoform 2C9
Cyclopropyl Piperidine Glycine Transporter Inhibitors
Thiazolyl MGLUR5 Antagonists and Methods for Their Use
Cgrp Receptor Antagonists
Diphenyl Substituted Alkanes as Flap Inhibitors
Application:
11/665,242 →
Publication:
US US20070287736A1
Cgrp Receptor Antagonists
Cgrp Receptor Antagonists
Cgrp Receptor Antagonists
2-Aminopyridine Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Process for {3-[2(R)-[(1R)-1-[3,5-Bis(Trifluoromethyl) Phenyl]Ethoxy]-3(S)-(4-Fluorophenyl)Morpholin-4-Yl]Methyl]-5-Oxo-4,5-Dihydro-[1,2,4]-Triazol-1-Yl}Phosphonic Acid
Fused Aminopiperidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Macrocyclic Tertiary Amine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Substituted Pyrazine Inhibitors of Akt
Inhibitors of Akt Activity
N-(2-Benzyl)-2-Phenylbutanamides as Androgen Receptor Modulators
Indoles Having Anti-Diabetic Activity
Hydroisoindoline Tachykinin Receptor Antagonists
Cgrp Receptor Antagonists
Antifungal Agents
Aminotetrahydropyrans as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Inhibitors of Checkpoint Kinases
2,3,4,6-Substituted Pyridyl Derivative Compounds Useful As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
Macrocyclic Aminopyridyl Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Pharmaceutical Formulation Containing a Release Rate Controlling Composition
Inhibitors of Akt Activity
Pharmaceutical Composition Containing an Anti-Nucleating Agent
Estrogen Receptor Modulators
Bicyclic Pyrimidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Antidiabetic Bicyclic Compounds
Inhibitors of Akt Activity
Tertiary Carbinamines Having Substituted Heterocycles Which Are Active as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Aminomethyl Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
Cgrp Receptor Antagonists
Purification Process for Plasmid Dna
Substituted Monocyclic Cgrp Receptor Antagonists
Novel anti-IGF-IR antibodies and uses thereof
Application:
11/801,080 →
Publication:
US US20080193445A1
Antidiabetic Bicyclic Compounds
Optimized Expression of Hpv 45 L1 in Yeast
Non Steroidal Glucocorticoid Receptor Modulators
Tyrosine Kinase Inhibitors
Optimized Expression of Hpv 31 L1 in Yeast
Fused-Aromatic Compounds Having Anti-Diabetic Activity
Composition for Inhibition of Cathepsin K
Novel Crystalline Forms of Antidiabetic Compounds
Cgrp Receptor Antagonists
Quinazolinone T-Type Calcium Channel Antagonists
Substituted Aryl and Heteroaryl Derivatives, Compositions Containing Such Compounds and Methods of Use
Hcv Protease Substrates
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Mitotic Kinesin Inhibitors
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Intelligent Refrigerator for Storing Pharmaceutical Product Containers
Inhibitors of Akt Activity
Method for improving the immunogenicity of plasmodium antigens
Application:
11/919,610 →
Publication:
US US20090047303A1
Hcv NS3 Protease Inhibitors
Peptide Conjugate Compositions and Methods for the Prevention and Treatment of Alzheimer's Disease
Hiv Integrase Inhibitors
Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment of Diabetes
Hydroisoindoline Tachykinin Receptor Antagonists
1-Hydroxycycloalkanecarboxamide Derivatives
Quinolone M1 Receptor Positive Allosteric Modulators
Benzocycloheptapyridines as Inhibitors of the Receptor Tyrosine Kinase Met
Inhibitors of Akt Activtiy
Crystalline Forms of MC4R Agonist and Process for Synthesis
Synthetic Gene Control Region
4-Fluoro-Piperidine T-Type Calcium Channel Antagonists
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
Modified Malonate Derivatives
Process for Synthesizing a Cetp Inhibitor
Interactive Product Selection System
Potassium Channel Inhibitors
Spirochromanone Derivatives as Acetyl Coenzyme a Carboxylase (Acc) Inhibitors
Synthesis and Crystalline Forms of NPY5 Antagonist
Process for Synthesizing a Substituted Pyrazole
Heterocyclic Benzodiazepine Cgrp Receptor Antagonists
Hcv NS3 Protease Inhibitors
Cyclic Ketal Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Fused Aminopiperidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
P38 Kinase Inhibiting Agents
Acetal Derivatives for the Treatment of Rna-Dependent Rna-Viral Infection
Radiolabeled Glycine Trasporter Inhibitors
Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators
Estrogen Receptor Modulators
Potassium Channel Inhibitors
Substituted Diazepan Orexin Receptor Antagonists
Inhibitors of Akt Activity
Non-Nucleoside Reverse Transcriptase Inhibitors
Angiotensin Ii Receptor Antagonists
Substituted Spirochromanone Derivatives
Substituted Amides
Biaryl Substituted Triazoles as Sodium Channel Blockers
Novel Pharmaceutical Phenylquinoline and Chromen-2-One Triazole Compounds
Substituted Pyridyoxy Amides
Antibodies Specific for Dkk-1
Papillomavirus Vaccine Compositions
Process for Making Spirolactone Compounds
Cgrp Receptor Antagonists
Triazole Derivatives Which Are Smo Antagonists
Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Cetp Inhibitors
Potassium Channel Inhibitors
Acylated Spiropiperidine Derivatives as Melanocortin-4 Receptor Modulators
Methods of Treating Cancers with SAHA, Carboplatin, and Paclitaxel and Other Combination Therapies
Application:
12/084,026 →
Publication:
US US20090105329A1
Piperdine Glycine Transporter Inhibitors
Histone Deacetylase Inhibitors with Aryl-Pyrazolyl-Motifs
Spirohydantoin Aryl Cgrp Receptor Antagonists
Bicyclic Spirohydantoin Cgrp Receptor Antagonists
Spirohydantoin Tricyclic Cgrp Receptor Antagonists
Spirolactam Tricyclic Cgrp Receptor Antagonists
Spirolactam Aryl Cgrp Receptor Antagonists
Spirolactam Bicyclic Cgrp Receptor Antagonists
Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Tricyclic Compounds Useful as Inhibitors of Kinases
Spirocyclic Compounds
Pharmaceutical Compositions of Combinations of Dipeptidyl Peptidase-4 Inhibitors with Metformin
Self-Emulsifying Formulations of Cetp Inhibitors
Fused Aminopiperidines as Dipeptidyl Peptidase-4 Inhibitors for the Treatment or Prevention of Diabetes
Morpholine Carboxamide Prokineticin Receptor Antagonists
Aminocyclohexanes as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Cetp Inhibitors
Cetp Inhibitors
Cholesteryl Ester Transfer Protein Inhibitors
1,3-Oxazolidin-2-One Derivatives Useful as Cetp Inhibitors
Rna Interference Mediated Inhibition of Hepatitis C Virus (Hcv) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Polycomb Group Protein EZH2 Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Placental Growth Factor Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Hypoxia Inducible Factor 1 (HIF1) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Stearoyl-Coa Desaturase (Scd) Gene Expression Using Short Interfering Nucelic Acid (Sina)
Rna Interference Mediated Inhibition of Cyclin D1 Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Platelet-Derived Endothelial Cell Growth Factor (ECGF1) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Substituted Monocyclic Cgrp Receptor Antagonists
Aminotetrahydropyrans as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Polymer Formulations of Cetp Inhibitors
Potassium Channel Inhibitors
Pyridine derivative potassium channel inhibitors
Tertiary Amine Derivative Potassium Channel Inhibitors For The Treatment Of Cardiovascular Diseases
Application:
12/223,356 →
Publication:
US US20090030043A1
Potassium Channel Inhibitors
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
A Pharmaceutical Composition Comprising Oxyntomodulin Derivatives and a Method for Reducing Body Weight Using the Composition
Inhibitors of Histone Deacetylase
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Diazepan Orexin Receptor Antagonists
Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators
Pyridyl Amide T-Type Calcium Channel Antagonists
Substitued [1,2,4]Triazolo[1,5-a]Pyrazines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Disubstituted Aniline Compounds
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Aryl-Fused Spirocyclic Compounds
Inhibitors of Janus Kinases
Compounds and Methods for Leukotriene Biosynthesis Inhibition
Eukaryotic Cell Display Systems
Diaryl Substituted Alkanes
Rapid method to determine inhibitor sensitivity of NS3/4A protease sequences cloned from clinical samples
Application:
12/308,010 →
Publication:
US US20090203008A1
Benzyl-Substituted Quinolone M1 Receptor Positive Allosteric Modulators
Tyrosine Kinase Inhibitors
Substituted Diazepan Orexin Receptor Antagonists
Application:
12/309,239 →
Publication:
US US20090192143A1
Bridged diazepan orexin receptor antagonists
Automated Determination of Chlamydia Infection-Forming Units
Application:
12/309,668 →
Publication:
US US20090317840A1
Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease
Application:
12/310,573 →
Publication:
US US20100298342A1
Method of Treatment Using Fatty Acid Synthesis Inhibitors
Piperidine and Pyrrolidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Substituted Imidazole as Bombesin Receptor Subtype-3 Modulators
Substituted Imidazoles as Bombesin Receptor Subtype-3 Modulators
Substituted Imidazoles as Bombesin Receptor Subtype-3 Modulators
Angiotensin Ii Receptor Antagonists
Antagonists of PCSK9
Application:
12/312,401 →
Publication:
US US20100041102A1
Fluorinated 4-Azasteroid Derivatives as Androgen Receptor Modulators
Tyrosine Kinase Inhibitors
Process for Preparing Chiral Dipeptidyl Peptidase -Iv Inhibitor Intermediates
Optimized Expression of Hpv 58 L1 in Yeast
Inhibitor of Vascular Endothelial Cell Growth Factor
1B20 PCSK9 Antagonists
1D05 PCSK9 Antagonists
Hcv NS3 Protease Inhibitors
Rna Interference Mediated Inhibition of CXCR4 Gene Expression Using Short Interfering Nuceleic Acid (Sina)
Diphenyl Substituted Alkanes
Estrogen Receptor Modulators
Substituted 4-Hydroxypyrimidine-5-Carboxamides
Substituted Amides
Cb-1 Receptor Modulator Formulations
Hepatitis C Virus Vaccine
Pyrazole Derivatives, Compositions Containing Such Compounds and Methods of Use
Substituted Pyrazoles, Compositions Containing Such Compounds and Methods of Use
Hydroxymethyl Pyrrolidines as Beta 3 Adrenergic Receptor Agonists
Cgrp Receptor Antagonists
Rna Interference Mediated Inhibition of Hepatitis C Virus (Hcv) Expression Using Short Interfering Nucleic Acid (Sina)
Difluorinated Piperidines for Treatment of Alzheimer's Disease and Related Conditions
Application:
12/439,010 →
Publication:
US US20100010041A1
Antidiabetic Bicyclic Compounds
Macrocyclic Spiropiperidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
2-[1-Phenyl-5-Hydroxy or Methoxy-4ALPHA-Methyl-Hexahydrocyclopenta [F]Indazole-5-Yl]Ethyl Phenyl Derivatives as Glucocorticoid Receptor Ligands
Hcv NS3 Protease Inhibitors
Hcv NS3 Protease Inhibitors
Hcv NS3 Protease Inhibitors
Hcv NS3 Protease Inhibitors
HCV NS3 Protease Inhibitors
Application:
12/447,342 →
Publication:
US US20100099695A1
Spiropiperidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
P38 Kinase Inhibiting Agents
Surface Display of Whole Antibodies in Eukaryotes
Macrocyclic Quinoxaline Compounds as Hcv NS3 Protease Inhibitors
Cicletanine Derivatives
Tricyclic Heteroaromatic Compounds as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Acyl Bipiperidinyl Compounds Useful as Gpr 119 Agonists
Constrained Spirocyclic Compounds as Cgrp Receptor Antagonists
Substituted Diazepine Sulfonamides as Bombesin Receptor Subtype-3 Modulators
Spirochromanon Derivatives
Bipiperidinyl Compounds, Compositions Containing Such Compounds and Methods of Treatment
Application:
12/518,575 →
Publication:
US US20100029688A1
Nucleoside Cyclic Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
Silylated Piperidine Derivatives
Benzazepine Compounds as Cgrp Receptor Antagonists
Application:
12/520,146 →
Publication:
US US20120065190A1
Nucleoside Aryl Phosphoramidates for the Treatment of Rna-Dependent Rna Viral Infection
Bicyclic Spiropiperidine Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Epidermidis
Method of Treating Atherosclerosis, Dyslipidemias and Related Conditions
Application:
12/526,001 →
Publication:
US US20100260841A1
Therapeutic Agents
Methods of Using SAHA for Treating HIV Infection
Application:
12/526,437 →
Publication:
US US20100324034A1
Piperazine Derivatives for Treatment of Ad and Related Conditions
Application:
12/526,687 →
Publication:
US US20100204230A1
Piperidine Derivatives
Formulations for Cathepsin K Inhibitors
Application:
12/527,876 →
Publication:
US US20090318560A1
Bipyridine Carboxamide Orexin Receptor Antagonists
Novel Crystalline Salt Form of an Antidiabetic Compound
In Vivo Hcv Resistance to Anti-Viral Inhibitors
Application:
12/529,785 →
Publication:
US US20100143886A1
Inhibitors of Janus Kinases and/or 3-Phosphoinositide-Dependent Protein Kinase-1
Monocyclic Anilide Spirolactam Cgrp Receptor Antagonists
Hexahydro-1H-4,7-Methanoisoindole-1,3-Dione Compounds
Mineralocorticoid Receptor Modulators
Tripyridyl Carboxamide Orexin Receptor Antagonists
Aminoalkylphenols, Methods of Using and Making the Same
Cb-1 Receptor Modulator Pharmaceutical Formulations
Application:
12/558,977 →
Publication:
US US20100081642A1
Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Hiv Integrase Inhibitors
Optimized Expression of Hpv 52 L1 in Yeast
Hydroxymethyl Ether Hydroisoindoline Tachykinin Receptor Antagonists
Method for Detecting Autoprocessed, Secreted PCSK9
Broadly Representative Antigen Sequences and Method for Selection
Application:
12/593,962 →
Publication:
US US20100183651A1
Cgrp Receptor Antagonists with Tertiary Amide, Sulfanamide, Carbamate and Urea End Groups
Aryl Heterocyclic Cgrp Receptor Antagonists
Bicyclic Anilide Heterocyclic Cgrp Receptor Antagonists
Crystalline Forms of Dihydropyrazolopyrimidinone
Method of Treatment Using Fused Aromatic Compounds Having Anti-Diabetic Activity
Spiroindalones
Cyclopropyl Pyrrolidine Orexin Receptor Antagonists
ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n
Application:
12/601,933 →
Publication:
US US20100166772A1
Carboxamide Heterocyclic Cgrp Receptor Antagonists
Tricyclic Anilide Heterocyclic Cgrp Receptor Antagonists
Tyrosine Kinase Inhibitors
Substituted Monocyclic Cgrp Receptor Antagonists
Aminotetrahydropyrans as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Inhibitors of Akt Activity
Angiotensin Ii Receptor Antagonists
Rna Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Treatment of Alzheimer's Disease Using Short Interfering Nucleic Acid (Sina)
Method for Determining Compatibility of an Active Pharmaceutical Ingredient with Materials
Application:
12/640,481 →
Publication:
US US20100216667A1
Rna Interference Mediated Inhibition of Matrix Metalloproteinase 13 (MMP13) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Cetp Inhibitors Derived from Benzoxazole Arylamides
Cetp Inhibitors Derived from Benzoxazole Arylamides
Cetp Inhibitors Derived from Benzoxazole Arylamides
Diphenyl Substituted Alkanes
Application:
12/665,223 →
Publication:
US US20100190761A1
4-Carboxybenzylamino Derivatives as Histone Deacetylase Inhibitors
Pyridyl Derivatives as Histone Deacetylase Inhibitors
Soluble Epoxide Hydrolase Inhibitors, Compositions Containing Such Compounds and Methods of Treatment
Macrocyclic Compounds As Antiviral Agents
Pyridine Carboxamide Orexin Receptor Antagonists
Heterocyclic Compounds as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Soluble Guanylate Cyclase Activators
Process for the Production of a Crystalline Glucagon Receptor Antagonist Compound
Inhibitors of Janus Kinases
Antifungal Agents
Diphenyl Substituted Cycloalkanes
Application:
12/682,150 →
Publication:
US US20110003815A1
Pyrazine Substituted Pyrrolopyridines as Inhibitors of Jak and PDK1
Cannabinoid-1 Receptor Modulators Useful for the Treatment of Alzheimer's Disease
Application:
12/682,846 →
Publication:
US US20100227844A1
Rna Interference Mediated Inhibition of Interleukin and Interleukin Receptor Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Vascular Cell Adhesion Molecule (Vcam) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Nogo and Nogo Receptor Gene Expression Using Short Interfering Nucleic Acid (Sina)
Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors for the Treatment of Diabetes
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Indole Derivatives as CRTH2 Receptor Antagonists
Soluble Guanylate Cyclase Activators
Rna Interference Mediated Inhibition of Protein Tyrosine Phosphatase-1B (Ptp-1B) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Guanosine Triphosphate (Gtp)-Binding Protein-Coupled Receptor Protein, BG37
Tricyclic Anilide Spirolactam Cgrp Receptor Antagonists
Microdrive and Modular Microdrive Assembly for Positioning Instruments in Animal Bodies
Application:
12/718,747 →
Publication:
US US20100211081A1
Rna Interference Mediated Inhibition of Stromal Cell-Derived Factor-1 (Sdf-1) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Quinolizidinone M1 Receptor Positive Allosteric Modulators
Antidiabetic Tricyclic Compounds
Tryptamine Sulfonamides as 5-HT6 Antagonists
Non-Nucleoside Reverse Transcriptase Inhibitors
Inhibitors of Janus Kinases
Mineralocorticoid Receptor Modulators
Application:
12/747,943 →
Publication:
US US20100261765A1
RNA Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (siNA)
Application:
12/748,075 →
Publication:
US US20100240730A1
Rna Interference Mediated Inhibition of Adenosine A1 Receptor (ADORA1) Gene Expression Using Short Interfering Rna
Application:
12/754,111 →
Publication:
US US20100305191A1
Diaryltriazoles as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Hiv Integrase Inhibitors
Inhibitors of the Renal Outer Medullary Potassium Channel
Benzylether and Benzylamino Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Rna Interference Mediated Inhibition of Human Immunodeficiency Virus (Hiv) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Platelet Derived Growth Factor (Pdgf) and Platelet Derived Growth Factor Receptor (Pdgfr) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Anti-Addl Monoclonal Antibody and Use Thereof
Process for Preparing N-Alkylated Hydroxypyrimidinone Compounds
Process for Preparing N-Substituted Hydroxypyrimidinone Carboxamides
Imidizo[1,2-A]Pyrazines Useful as Ahcy Hydrolase Inhibitors
Angiotensin Ii Receptor Antagonists
Beta-Lactamase Inhibitors
Quinolizidinone M1 Receptor Positive Allosteric Modulators
Cetp Inhibitors
Anti-Addl Antibodies and Uses Thereof
Cgrp Receptor Antagonists
Substituted Imidazole 4-Carboxamides as Cholecystokinin-1 Receptor Modulators
System and Method for Segmenting M-Mode Ultrasound Images Showing Blood Vessel Wall Motion Over Time
Process for {3-[2(R)-[(1R)-1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethoxy]-3(S)-(4-Fluorophenyl)Morpholin-4-Yl]Methyl]-5-Oxo-4,5-Dihydro-[1,2,4]-Triazol-1-Yl}Phosphonic Acid
Prodrugs of Cgrp Receptor Antagonists
Angiotensin Ii Receptor Antagonists
Pharmaceutical Compositions of a Combination of Metformin and a Dipeptidyl Peptidase-Iv Inhibitor
Application:
12/864,885 →
Publication:
US US20100330177A1
Quinolizidinone M1 Receptor Positive Allosteric Modulators
Fused Pyridone M1 Receptor Positive Allosteric Modulators
Imidazobenzazepine Cgrp Receptor Antagonists
Substituted 5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Anti-Addl Antibodies and Uses Thereof
Therapeutic Compounds
2-Aminoimidazole Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Soluble Epoxide Hydrolase Inhibitors, Compositions Containing Such Compounds and Methods of Treatment
Application:
12/919,323 →
Publication:
US US20110003849A1
High Throughput Protein Interaction Assay
Application:
12/921,890 →
Publication:
US US20110014226A1
Pd-1 Binding Proteins
Quinolizidinone M1 Receptor Positive Allosteric Modulators
Methods and Gene Expression Signature for Assessing Growth Factor Signaling Pathway Regulation Status
Monocyclic Cgrp Receptor Antagonists
Substituted Cyclopropyl Compounds, Compositions Containing Such Compounds and Methods of Treatment
Pancreatic Beta-Cell Mass Biomarker
Application:
12/936,827 →
Publication:
US US20110123443A1
Rna Interference Mediated Inhibition of Muscarinic Colinergic Receptor Gene Expression Using Short Interfering Nucleic Acid (Sina)
Diagnosis and Prognosis of Breast Cancer Patients
Application:
12/953,314 →
Publication:
US US20110301048A1
Inhibitors of Janus Kinases
Cyclobutyl Sulfones as Notch Sparing Gamma Secretase Inhibitors
Microrna Biomarkers of Tissue Injury
Application:
12/989,246 →
Publication:
US US20110111976A1
Hcv NS3 Protease Inhibitors
4-Oxo,1-4-Dihydroquinoline M1 Receptor Positive Allosteric Modulators
Formulations for Cathepsin K Inhibitors
Application:
12/992,124 →
Publication:
US US20110065800A1
Angiotensin Ii Receptor Antagonists
Yeast Strain for the Production of Proteins with Terminal Alpha-1,3-Linked Galactose
Application:
12/995,284 →
Publication:
US US20110086054A1
Imidazole Derivatives Useful as Inhibitors of Faah
Pyrazole Derivatives Useful as Inhibitors of Faah
Application:
12/996,435 →
Publication:
US US20110144056A1
Process for Producing Bicycloaniline Derivatives
Inhibitors of Janus Kinases
Inhibitors of Janus Kinases
Method of Using Compositions Comprising MIR-192 and/or MIR-215 for the Treatment of Cancer
Application:
13/003,536 →
Publication:
US US20110118337A1
Pyridyl Amide T-Type Calcium Channel Antagonists
Thiazolyl MGLUR5 Antagonists and Methods for Their Use
15-Valent Pneumococcal Polysaccharide-Protein Conjugate Vaccine Composition
Diphenyl Substituted Alkanes as Flap Inhibitors
Pharmaceutical Composition Comprising Oxyntomodulin Derivatives and a Method for Reducing Body Weight Using the Composition
Methods for the Prediction of Short-Term and Long-Term Cognitive Decline in Alzheimer's Disease Patients Using Csf Biomarkers
Application:
13/055,842 →
Publication:
US US20110182820A1
Inhibitors of Janus Kinases
Variant Hcmv PP65, IE1, and IE2 Polynucleotides and Uses Thereof
Application:
13/056,899 →
Publication:
US US20110136896A1
Urea Derivatives as Antibacterial Agents
Application:
13/057,505 →
Publication:
US US20110212080A1
Antifungal Agents
Pyrimidine Derivatives for Treatment of Alzheimer's Disease
Purine Derivatives for Treatment of Alzheimer's Disease
Application:
13/058,232 →
Publication:
US US20110251172A1
Non-Amidic Linkers with Branched Termini as Cgrp Receptor Antagonists
Lipid Nanoparticles and Components for Delivery of Nucleic Acids
Application:
13/059,491 →
Publication:
US US20110224447A1
Ahcy Hydrolase Inhibitors for Treatment of Hyper Homocysteinemia
Nucleoside Derivatives as Inhibitors of Viral Polymerases
Application:
13/061,746 →
Publication:
US US20110306573A1
Pharmaceutical Compositions of Atorvastatin
Application:
13/062,891 →
Publication:
US US20110165239A1
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
1,3-Oxazolidin -2-One Derivatives Useful as Cetp Inhibitors
Rna Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
Rna Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes
Angiotensin Ii Receptor Antagonists
Rna Interference Mediated Inhibition of Gene Expression Using Chemically Modified Short Interfering Nucleic Acid (Sina)
Macrocyclic Quinoxaline Compounds as Hcv NS3 Protease Inhibitors
Cgrp Receptor Antagonists
Application:
13/122,769 →
Publication:
US US20110245240A1
Isonicotinamide Orexin Receptor Antagonists
Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Substituted Bicyclic Amines for the Treatment of Diabetes
Disubstituted Azepan Orexin Receptor Antagonists
Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Novel Cyclic Benzimidazole Derivatives Useful as Anti-Diabetic Agents
Novel Substituted Azabenzoxazoles
Application:
13/125,939 →
Publication:
US US20110212031A1
Benzimidazole and Aza-Benzimidazole Carboxamides
Soluble Guanylate Cyclase Activators
Aryl Methyl Benzoquinazolinine M1 Receptor Positive Allosteric Modulators
Inhibitors of Diacylglycerol Acyltransferase
Biaryl Carboxamides
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
Application:
13/130,964 →
Publication:
US US20110229508A1
Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
Application:
13/130,974 →
Publication:
US US20110229509A1
Inhibitors of Phosphoinositide Dependent Kinase 1 (PDK1)
RNA Interference Mediated Inhibition of Epithelial Sodium Channel (ENaC) Gene Expression Using Short Interfering Nucleic Acid (siNA)
Application:
13/131,375 →
Publication:
US US20110288154A1
Method for Treating Alzheimer's Disease and Related Conditions
Application:
13/133,080 →
Publication:
US US20110263580A1
Packaging for Oxygen-Sensitive Pharmaceutical Products
Application:
13/139,020 →
Publication:
US US20110240511A1
Triazole Derivatives for Treatment of Alzheimer's Disease
Glucagon Receptor Antagonist Compounds
Crystalline Polymorphic Forms of an Antidiabetic Compound
Trifluoromethylsulfonamide Gamma Secretase Inhibitor
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Application:
13/146,220 →
Publication:
US US20110281795A1
Inhibitors of AKT Activity
Application:
13/147,392 →
Publication:
US US20110288090A1
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
RNA INTERFERENCE MEDIATED INHIBITION OF TNF AND TNF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
Application:
13/165,635 →
Publication:
US US20120004403A1
RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
Application:
13/179,785 →
Publication:
US US20120041184A1
Inactivated Varicella Zoster Virus Vaccines, Methods of Production, and Uses Thereof
Application:
13/198,191 →
Publication:
US US20120034267A1
Glucagon Receptor Antagonist Compounds, Compositions Containing Such Compounds and Methods of Use
Methods for Characterizing Agonists and Partial Agonists of Target Molecules
Substituted Quinoxalines as Inhibitors of Fatty Acid Binding Protein
Surface Display of Whole Antibodies in Eukaryotes
RNA Interference Mediated Inhibition of BTB and CNC Homology 1, Basic Leucine Zipper Transcription Factor 1 (BACH1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
Application:
13/255,673 →
Publication:
US US20120016010A1
RNA Interference Mediated Inhibition of Connective Tissue Growth Factor (CTGF) Gene Expression Using Short Interfering Nucleic Acid (siNA)
Application:
13/255,695 →
Publication:
US US20120016011A1
RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)
Application:
13/255,725 →
Publication:
US US20120029054A1
Rna Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 6 (STAT6) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Application:
13/255,744 →
Publication:
US US20120035247A1
Inhibitors of Akt Activity
Rna Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (Sina)
Application:
13/256,089 →
Publication:
US US20120010272A1
RNA Interference Mediated Inhibition of the FC Epsilon R1 Alpha Gene
RNA Interference Mediated Inhibition of the Nerve Growth Factor Beta Chain (NGFB) Gene Expression Using Short Interfering Nucleic Acid (siNA)
Application:
13/256,105 →
Publication:
US US20120004281A1
RNA Interference Mediated Inhibition of Signal Transducer and Activator of Transcription 1 (STAT1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
Application:
13/256,146 →
Publication:
US US20120022142A1
RNA Interference Mediated Inhibition of the Thymic Stromal Lymphopoietin (TSLP) Gene Expression Using Short Interfering Nucliec Acid (siNA)
Application:
13/256,155 →
Publication:
US US20120022143A1
RNA Interference Mediated Inhibition of the Intercellular Adhesion Molecule 1 (ICAM-1) Gene Expression Using Short Interfering Nucleic Acid (siNA)
Application:
13/256,170 →
Publication:
US US20120004282A1
Cgrp Receptor Antagonists
Compositions and Methods for Treating Cancer
Substituted Spirocyclic Amines Useful as Antidiabetic Compounds
Application:
13/265,146 →
Publication:
US US20120041012A1
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Piperidinone Carboxamide Azaindane Cgrp Receptor Antagonists
Pharmaceutical Compositions of Hdac Inhibitors and Chelatable Metal Compounds, and Metal-Hdac Inhibitor Chelate Complexes
Application:
13/297,994 →
Publication:
US US20120142770A1
Pharmaceutical Compositions of Combinations of Dipeptidyl Peptidase-4 Inhibitors with Pioglitazone
Application:
13/319,718 →
Publication:
US US20120059011A1
Anti-ADDL Monoclonal Antibody and Use Thereof
Anti-ADDL Antibodies and Uses Thereof
Tetrahydronapthyridine Orexin Receptor Antagonists
Application:
13/382,447 →
Publication:
US US20120101106A1
Quinolinone PDE2 Inhibitors
Methods for Producing High Concentration Lyophilized Pharmaceutical Formulations
Application:
13/387,268 →
Publication:
US US20120121580A1
Hepatitis C Virus NS3 Protease Inhibitors
Aminotetrahydropyrans as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment or Prevention of Diabetes
Novel Cationic Lipids with Various Head Groups for Oligonucleotide Delivery
Substituted Aminopiperidines as Dipeptidyl Peptidase-Iv Inhibitors for the Treatment of Diabetes
Jak Inhibition Blocks Rna Interference Associated Toxicities
Application:
13/391,393 →
Publication:
US US20120157500A1
Diaryl Substituted Alkanes
Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
Application:
13/423,618 →
Publication:
US US20120178750A1
Bipiperidinyl Compounds, Compositions, Containing Such Compounds and Methods of Treatment
Preparation of Crystalline Forms of Dihydropyrazolopyrimidinone
Tablet
Patent:
425,614 →
Application:
29/103,611 →
Tablet
Patent:
434,846 →
Application:
29/108,430 →
Tablet
Patent:
431,076 →
Application:
29/108,431 →
Pharmaceutical Kit
Patent:
457,246 →
Application:
29/115,771 →
Pharmaceutical Kit
Patent:
480,958 →
Application:
29/164,695 →
Tablet
Patent:
515,202 →
Application:
29/209,646 →
Homoerythromycin a Derivatives Modified at the 4"-and 8A-Positions
Patent:
5,985,844 →
Application:
07/855,242 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Change of Name
Jan 27, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023852/0595 →
Change of Name
Jan 27, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023854/0563 →
Change of Name
Jan 28, 2010
From: MERCK & CO., INC.
To: MERCK SHARP & DOHME CORP.
Reel/Frame 023861/0293 →
Merger
Aug 27, 2012
From: MERCK SHARP & DOHME CORP.
To: SCHERING CORPORATION
Reel/Frame 028850/0515 →
Assignment of Assignor's Interest
Jul 16, 2014
From: MERCK SHARP & DOHME CORP.
To: MERIAL LIMITED
Reel/Frame 033323/0013 →